Objectives: To test CIDP patients for IgM positivity towards CNTN1.
Patients:
NUMBER | CODE |
---|---|
1 | 18-502 |
2 | 18-503 |
3 | 18-504 |
4 | 18-505 |
5 | 18-506 |
6 | 18-507 |
7 | 18-508 |
8 | 18-509 |
9 | 18-510 |
10 | 18-511 |
11 | 18-512 |
12 | 18-513 |
13 | 18-514 |
14 | 18-515 |
15 | 18-516 |
16 | 18-517 |
17 | 18-518 |
18 | 18-519 |
19 | 18-520 |
20 | 18-521 |
21 | 18-522 |
22 | 18-523 |
23 | 18-524 |
24 | 18-525 |
25 | 18-526 |
26 | 18-527 |
27 | 18-528 |
28 | 18-529 |
29 | 18-530 |
30 | 18-531 |
31 | 18-532 |
32 | 18-533 |
33 | 18-534 |
34 | 18-535 |
35 | 18-536 |
36 | 18-537 |
37 | 18-538 |
38 | 18-539 |
39 | 18-540 |
40 | 18-541 |
41 | 18-542 |
42 | 18-543 |
43 | 18-544 |
44 | 18-545 |
45 | 18-546 |
46 | 18-547 |
47 | 18-548 |
48 | CTRL - |
CNTN1 ICC:
- HEKs 293 Cells Transfection: 15.02.2018
- Blocking solution: Rabbit serum diluted 1/40 in PBS.
- Patient’s sera diluted 1/10 for IgM with rabbit serum 1/40.
- Primary antibody: AF904 diluted 1/1000.
- Secondary antibodies: RAG 488 + RAH 594 IgM (1/1000)
- Vectashield mounting medium.
Results: All samples were negative.